Capitalize on the recent 5% to 7% after-hours dip in Rocket Lab USA, Inc. (RKLB) to build a long-term position, keeping in mind that the delayed Neutron rocket flight timeline pushes major profitability catalysts toward early 2027. Treat the current after-hours volatility in AST SpaceMobile, Inc. (ASTS) as a speculative accumulation window, but tie your holding period to the successful commercial deployment of upcoming Bluebird satellites. Use the recent 5% to 6% pullback in Hims & Hers Health, Inc. (HIMS) to buy shares following strong subscriber growth to 2.9 million, while closely monitoring operating expenses for improvements in bottom-line profitability. Approach Palantir Technologies Inc. (PLTR) with extreme caution near its $175.23 recent close, noting that high-profile short positions like March 2027 $100 strike put options signal severe valuation concerns despite strong annual revenue projections. Ride the structural AI infrastructure boom fueled by NVIDIA Corporation's (NVDA) new $500 billion financing partnership, while keeping a close eye on downstream private credit leverage and macroeconomic risks.

Rocket Lab USA, Inc. (RKLB)

• Rocket Lab reported fourth-quarter revenue of $234 million, representing a 62% year-over-year increase, which was a slight beat of about $4 million.
• Earnings per share (EPS) came in line with expectations at a loss of $0.8 cents, with an EBITDA loss guided at $23 million.
• The company announced a backlog of $2.36 billion (up 137% year-over-year), a dedicated Neutron launch contract with Kepler Communications, and the unveiling of "Ghost" (Global Hypersonic and Orbital Spaceport Technology), a deployable containerized launch system.
• Management cautioned of fresh risks regarding the Neutron rocket debut, confirming delivery to the launch pad in the fourth quarter, but stopping short of guaranteeing it will fly this year (with expectations shifting to early 2027).
• The stock experienced downward pressure, trading down around 5% to 7% in after-hours reactions.

Takeaways

• While revenue growth and backlog expansion remain robust, the delay in the actual flight timeline of the Neutron rocket may introduce near-term volatility and require investors to extend their patience regarding profitability.

AST SpaceMobile, Inc. (ASTS)

• ASTS reported a double miss on earnings, with an EPS loss of $0.77 cents (missing expectations by 165%) and revenue coming in at $31 million (missing the $34 million estimate).
• Despite the miss, the company highlighted a revenue backlog of $1.3 billion, with Bluebirds 14 to 16 expected to ship shortly and units 17 to 46 in various stages of production.
• Management is preparing to initiate beta services with select strategic partners.
• The stock saw initial after-hours volatility, swinging from up 4% down to a 2% to 4% loss following the earnings release.

Takeaways

• As a pre-revenue company focusing heavily on manufacturing and satellite constellation expansion, near-term financial misses are common, but long-term success will hinge on the successful deployment and commercialization of the Bluebird constellation.

Hims & Hers Health, Inc. (HIMS)

• Hims & Hers reported second-quarter revenue of $753 million (beating expectations of $730 million), representing a 38% year-over-year increase, alongside subscriber growth to 2.9 million (beating the expected 2.74 million).
• The company raised its full-year revenue guide to $3.3 billion and beat Q3 adjusted EBITDA estimates at $95 million.
• However, the company experienced a significant EPS miss at a loss of $0.37 cents (compared to an expected loss of $0.05 cents), largely driven by an increase in operating expenses and potential legal costs, causing the stock to drop 5% to 6% after hours.

Takeaways

• Strong top-line growth and subscriber additions demonstrate healthy underlying business momentum, but investors must monitor operating expenses and legal costs to see when these metrics translate into bottom-line profitability.

Palantir Technologies Inc. (PLTR)

• Notable investor Michael Burry purchased March 2027 $100 strike put options on Palantir, publicly stating that the company's shares are worth under $1 in the long run due to concerns over high stock-based compensation and valuation.
• The podcast host strongly disagreed with this analysis, pointing out the absurdity of a $1 valuation given Palantir's projected $8.5 billion in annual revenue and strong recent earnings.
• Palantir recently closed around $175.23, having gained approximately 40% over the preceding weeks.

Takeaways

• High-flying artificial intelligence software stocks like Palantir continue to attract dramatic short bets from prominent investors, highlighting ongoing debates over valuation and stock-based dilution despite strong top-line performance.

NVIDIA Corporation (NVDA)

• NVIDIA partnered with six premier financial institutions (Apollo, BlackRock, Blackstone, Brookfield, Goldman Sachs, and KKR) on a massive $500 billion financing deal through memorandums of understanding (MOUs).
• The initiative aims to create dedicated capital pools to fund AI infrastructure, data centers, power generation, and compute assets explicitly for NVIDIA customers and its CUDA ecosystem.
• CEO Jensen Butler emphasized during a live panel that compute is transitioning into a new, investable asset class, projecting that the semiconductor industry needs to scale up 10 times over the next decade.
• While the bull case views this as an incredible catalyst that secures half a trillion dollars for NVIDIA's ecosystem without straining the company's balance sheet, the bear case questions whether the private credit leverage, potential circular financing, and ROI of downstream AI applications could pose systemic risks.
• NVIDIA stock traded relatively flat to up slightly (+0.5%) in after-hours trading as the market digested the massive scale of the announcement.

Takeaways

• The move reinforces the massive long-term capital commitment flowing into the AI infrastructure and semiconductor space, benefiting hyperscalers, neoclouds, and memory providers (such as Micron), though investors should remain mindful of macroeconomic leverage and execution risks.